David C W Mabey Selected Research

Trachoma

5/2023	Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia.
1/2023	A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma.
1/2022	The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
11/2020	Facial cleanliness indicators by time of day: results of a cross-sectional trachoma prevalence survey in Senegal.
11/2019	Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection.
10/2019	Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
1/2019	Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma.
1/2019	Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
1/2018	Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis.
1/2018	Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C W Mabey Research Topics

Disease

55	Trachoma 05/2023 - 07/2003
27	Infections 01/2023 - 10/2004
15	Cicatrix (Scar) 01/2020 - 04/2006
13	Trichiasis 01/2019 - 03/2006
5	Yaws 01/2021 - 01/2015
4	Inflammation (Inflammations) 01/2019 - 01/2013
4	Eye Infections 03/2014 - 10/2005
3	Fibrosis (Cirrhosis) 01/2020 - 04/2006
3	Corneal Opacity 03/2015 - 12/2011
2	Neglected Diseases 10/2023 - 01/2023
2	Scabies (Sarcoptic Mange) 12/2020 - 01/2019
2	Ulcer 07/2009 - 07/2007
2	Blindness (Hysterical Blindness) 01/2009 - 09/2005
1	Urethritis 11/2019
1	Impetigo (Impetigo Contagiosa) 01/2019
1	Constipation 01/2018
1	Gastritis 01/2018
1	Vision Disorders (Hemeralopia) 03/2015
1	Conjunctival Diseases 01/2013
1	Bacterial Infections (Bacterial Infection) 01/2012
1	Entropion 01/2012
1	Metaplasia 01/2011
1	Herpes Genitalis (Genital Herpes) 07/2009
1	Reinfection 01/2009
1	Neoplasms (Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

26	Azithromycin (Zithromax)FDA LinkGeneric 05/2023 - 07/2003
19	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 07/2003
9	CytokinesIBA 01/2020 - 12/2004
5	AntibodiesIBA 01/2021 - 11/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2006
4	AntigensIBA 01/2021 - 01/2011
4	RNA (Ribonucleic Acid)IBA 02/2016 - 07/2007
3	Ivermectin (Mectizan)FDA Link 05/2023 - 01/2019
3	VaccinesIBA 03/2014 - 08/2006
3	Interferon-gamma (Interferon, gamma)IBA 03/2014 - 12/2004
2	ReaginsIBA 01/2021 - 01/2018
2	ChemokinesIBA 01/2020 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2008
2	Nucleic AcidsIBA 11/2019 - 02/2006
2	MucinsIBA 01/2019 - 01/2017
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 07/2010
2	MacrolidesIBA 01/2017 - 09/2003
2	MicroRNAs (MicroRNA)IBA 02/2016 - 01/2013
2	LigandsIBA 03/2014 - 01/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 12/2004
2	Metalloproteases (Metalloproteinases)IBA 01/2012 - 12/2004
2	S100 Calcium Binding Protein A7IBA 01/2012 - 01/2012
2	16S Ribosomal RNAIBA 08/2006 - 02/2006
2	Tetracycline (Achromycin)FDA LinkGeneric 11/2004 - 07/2003
1	Albendazole (Albenza)FDA Link 05/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Antimicrobial PeptidesIBA 01/2020
1	InterleukinsIBA 01/2020
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2020
1	InterferonsIBA 01/2019
1	CoagulaseIBA 01/2017
1	CollagenIBA 01/2016
1	Cell Surface ReceptorsIBA 11/2015
1	HLA-C Antigens (HLA-C)IBA 03/2014
1	Messenger RNA (mRNA)IBA 01/2013
1	GATIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	Interleukin-17 (Interleukin 17)IBA 12/2011
1	antineoplaston A10 (A 10)IBA 12/2011
1	Silk FDA Link 12/2011
1	AgarIBA 07/2011
1	Keratins (Keratin)IBA 01/2011
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 08/2010
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2010
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2009
1	Transcription Factors (Transcription Factor)IBA 08/2006
1	Amino Acids FDA Link 04/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2006
1	EnzymesIBA 04/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2006
1	Peptides (Polypeptides)IBA 03/2006
1	PerforinIBA 12/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2004
1	Ointments (Pastes)IBA 11/2004
1	Combined VaccinesIBA 09/2003

Therapy/Procedure

16	Mass Drug Administration 10/2023 - 01/2009
6	Hair Removal (Depilation) 01/2017 - 03/2006
3	Aftercare (After-Treatment) 01/2021 - 11/2004
2	Therapeutics 11/2011 - 07/2009
1	Surgical Instruments (Clip) 03/2015
1	Sutures (Suture) 12/2011